G Medical Innovations Holdings Limited (ASX: GMV)
G Medical is a healthcare related small-cap stock with a market capitalisation of 108.69m, whose securities were reported to be placed in a Trading Halt Session State at the request of the Company, pending the release of an announcement until the earlier of the commencement of normal trading on 12 April 2018, or release of the announcement. The stock was initially seen to move up about 4.7% on April 10, 2018, and lately, CEO, Yacov Geva through an on-market trading acquired an additional chunk of securities (about 1,000,000). The group also indicated for the release of options (5,240,386) expiring on May 2020 at $0.30 and escrowed until May 01, 2018. The group is aiming to be at the forefront of the digital health revolution, developing the next generation of mobile health (mHealth) technologies; and has Prizma sensors and medical app that can integrate well with smartphones.
.png)
Product features (Source: Company Reports)
GMV has indicated for good opportunities given the fact that the bulk of the global revenues originate from services for diagnostic, monitoring, chronic disease management, and ageing applications; and mobile tools and healthcare apps have grown at 26% and 14% cumulative annual growth rate (CAGR), respectively, between 2013 to 2016. The group has the product suite that helps in monitoring patient based on transmissions made via 4G/WiFi to the G Medical Innovations Cloud that further transmits data to Monitoring Center 24/7/365, and diagnostics is compiled as a complete report sent to physician who can directly make indications to the patients. The group indicated for CFDA approval of Prizma & Guangzhou facilities for 1H FY18 while VSMS/GMP FDA approval has been earmarked for 2H FY18. Overall, rapidly rising population and need of healthcare systems with swift adoption of smartphones and tablet devices are paving the path for an increased use of mhealth apps. Thus, the emerging landscape sets a good zone for opportunity for GMV. In view of this, we believe it will be crucial to keep an eye on this digital healthcare stock.
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.